tirzepatide zepbound mounjaro Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine A head-to-head study found that

These hormones are released by the gut in response to nutrient intake and play key roles in stimulating insulin secretion, reducing glucagon levels, delaying gastric emptying, and influencing appetite

After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025

Patient 1 and Patient 3 did not develop diabetes over the time of observation

ja.ma/46SHwdO Join the conversation

The benchmark index is MSCI US IMI Info Technology 25/50

Clinical trials showed significant weight loss at every dose level, with 5mg producing an average of 16% body weight reduction in the SURMOUNT-1 trial